Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
20,081Documents
100Full text
2026-09-13Last indexed
Recent documents from this source
- Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer#383563
- Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)#383562
- Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer#383561
- Text-based Intervention to Minimize the Time Burden of Routine Cancer Care#383560
- CAR-T Hepatic Artery Infusions or Pancreatic Venous Infusions for CEA-Expressing Liver Metastases or Pancreas Cancer#383559
- Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG#383558
- Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers#383557
- Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment#383556
- Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma#383555
- Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma#383554
- alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells#383553
- Gene-Modified HIV-Protected Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma#383552
- Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer#383551
- Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer#383550
- Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors#383549
- Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors#383548
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes#383547
- A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers#383546
- Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia#383545
- Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer#383544
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).